The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
SCF ubiquitin ligase-targeted therapies
Open accessAbstract
The clinical successes of proteasome inhibitors for the treatment of cancer have highlighted the therapeutic potential of targeting this protein degradation system. However, proteasome inhibitors prevent the degradation of numerous proteins, which may cause adverse effects. Increased specificity could be achieved by inhibiting the components of the ubiquitin–proteasome system that target specific subsets of proteins for degradation. F-box proteins are the substrate-targeting subunits of SKP1–CUL1–F-box protein (SCF) ubiquitin ligase complexes. Through the degradation of a plethora of diverse substrates, SCF ubiquitin ligases control a multitude of processes at the cellular and organismal levels, and their dysregulation is implicated in many pathologies. SCF ubiquitin ligases are characterized by their high specificity for substrates, and these ligases therefore represent promising drug targets. However, the potential for therapeutic manipulation of SCF complexes remains an underdeveloped area. This Review explores and discusses potential strategies to target SCF-mediated biological processes to treat human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Komander, D., & Rape, M. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060310-170328 · Cited by 3,679
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715
RING Domain E3 Ubiquitin Ligases
Deshaies, R. J., & Joazeiro, C. A. P. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.101807.093809 · Cited by 2,679
Sakamoto, K. M., Kim, K. B., Kumagai, A., Mercurio, F., Crews, C. M., & Deshaies, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141230798 · Cited by 2,609
Targeting cancer with small molecule kinase inhibitors
Zhang, J., Yang, P. L., & Gray, N. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2559 · Cited by 2,576
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,504
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
DIAGRAM Consortium, Dupuis, J., GIANT Consortium, Global BPgen Consortium, Anders Hamsten on behalf of Procardis Consortium, the MAGIC investigators, Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., et al. (2010) · Nature Genetics · doi:10.1038/ng.520 · Cited by 2,166
Identification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Krönke, J., Udeshi, N. D., Narla, A., Grauman, P., Hurst, S. N., McConkey, M., Svinkina, T., Heckl, D., Comer, E., Li, X., et al. (2014) · Science · doi:10.1126/science.1244851 · Cited by 1,879
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Wilhelm, S., Carter, C., Lynch, M., Lowinger, T., Dumas, J., Smith, R. A., Schwartz, B., Simantov, R., & Kelley, S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2130 · Cited by 1,829
Mechanism of auxin perception by the TIR1 ubiquitin ligase
Tan, X., Calderon-Villalobos, L. I. A., Sharon, M., Zheng, C., Robinson, C. V., Estelle, M., & Zheng, N. (2007) · Nature · doi:10.1038/nature05731 · Cited by 1,688
An auxin-based degron system for the rapid depletion of proteins in nonplant cells
Nishimura, K., Fukagawa, T., Takisawa, H., Kakimoto, T., & Kanemaki, M. (2009) · Nature Methods · doi:10.1038/nmeth.1401 · Cited by 1,663
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Lu, G., Middleton, R. E., Sun, H., Naniong, M., Ott, C. J., Mitsiades, C. S., Wong, K.-K., Bradner, J. E., & Kaelin, W. G. (2014) · Science · doi:10.1126/science.1244917 · Cited by 1,583
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Self-citationAn h Per2 Phosphorylation Site Mutation in Familial Advanced Sleep Phase Syndrome
Toh, K. L., Jones, C. R., He, Y., Eide, E. J., Hinz, W. A., Virshup, D. M., Ptáček, L. J., & Fu, Y.-H. (2001) · Science · doi:10.1126/science.1057499 · Cited by 1,460
Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236
Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide
Fischer, E. S., Böhm, K., Lydeard, J. R., Yang, H., Stadler, M. B., Cavadini, S., Nagel, J., Serluca, F., Acker, V., Lingaraju, G. M., et al. (2014) · Nature · doi:10.1038/nature13527 · Cited by 1,141
The SCF ubiquitin ligase: insights into a molecular machine
Cardozo, T., & Pagano, M. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1471 · Cited by 1,114
Self-citationWelcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084
Diverse somatic mutation patterns and pathway alterations in human cancers
Kan, Z., Jaiswal, B. S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H. M., Yue, P., Haverty, P. M., Bourgon, R., Zheng, J., et al. (2010) · Nature · doi:10.1038/nature09208 · Cited by 1,027
Lohr, J. G., Stojanov, P., Lawrence, M. S., Auclair, D., Chapuy, B., Sougnez, C., Cruz-Gordillo, P., Knoechel, B., Asmann, Y. W., Slager, S. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121343109 · Cited by 974
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways
Schulman, B. A., & Wade Harper, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2673 · Cited by 943
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
Lee, B.-H., Lee, M. J., Park, S., Oh, D.-C., Elsasser, S., Chen, P.-C., Gartner, C., Dimova, N., Hanna, J., Gygi, S. P., et al. (2010) · Nature · doi:10.1038/nature09299 · Cited by 893
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer
Frescas, D., & Pagano, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2396 · Cited by 890
Self-citationTsvetkov, L. M., Yeh, K.-H., Lee, S.-J., Sun, H., & Zhang, H. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80290-5 · Cited by 791
Nakayama, K. (2000) · The EMBO Journal · doi:10.1093/emboj/19.9.2069 · Cited by 717
New insights into ubiquitin E3 ligase mechanism
Berndsen, C. E., & Wolberger, C. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2780 · Cited by 714
Systematic analysis and nomenclature of mammalian F-box proteins
Jin, J., Cardozo, T., Lovering, R. C., Elledge, S. J., Pagano, M., & Harper, J. W. (2004) · Genes & Development · doi:10.1101/gad.1255304 · Cited by 712
Self-citationp45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
Sutterlüty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Müller, U., & Krek, W. (1999) · Nature Cell Biology · doi:10.1038/12027 · Cited by 700
Mechanisms and function of substrate recruitment by F-box proteins
Skaar, J. R., Pagan, J. K., & Pagano, M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3582 · Cited by 689
Self-citationTargeting the cancer kinome through polypharmacology
Knight, Z. A., Lin, H., & Shokat, K. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2787 · Cited by 674
Identification of the receptor component of the IκBα–ubiquitin ligase
Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A. M., Andersen, J. S., Mann, M., Mercurio, F., & Ben-Neriah, Y. (1998) · Nature · doi:10.1038/25159 · Cited by 654
Schneekloth, A. R., Pucheault, M., Tae, H. S., & Crews, C. M. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.114 · Cited by 635
HECT and RING finger families of E3 ubiquitin ligases at a glance
Metzger, M. B., Hristova, V. A., & Weissman, A. M. (2012) · Journal of Cell Science · doi:10.1242/jcs.091777 · Cited by 630
Chauhan, D., Tian, Z., Nicholson, B., Kumar, K. G. S., Zhou, B., Carrasco, R., McDermott, J. L., Leach, C. A., Fulcinniti, M., Kodrasov, M. P., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.007 · Cited by 589
Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis
Zhang, E. E., Liu, Y., Dentin, R., Pongsawakul, P. Y., Liu, A. C., Hirota, T., Nusinow, D. A., Sun, X., Landais, S., Kodama, Y., et al. (2010) · Nature Medicine · doi:10.1038/nm.2214 · Cited by 567
Siepka, S. M., Yoo, S.-H., Park, J., Song, W., Kumar, V., Hu, Y., Lee, C., & Takahashi, J. S. (2007) · Cell · doi:10.1016/j.cell.2007.04.030 · Cited by 537
MDM2 inhibitors for cancer therapy
Vassilev, L. T. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.002 · Cited by 532
Roles of F-box proteins in cancer
Wang, Z., Liu, P., Inuzuka, H., & Wei, W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3700 · Cited by 523
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
Pawlotsky, J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.003 · Cited by 518
Busino, L., Bassermann, F., Maiolica, A., Lee, C., Nolan, P. M., Godinho, S. I. H., Draetta, G. F., & Pagano, M. (2007) · Science · doi:10.1126/science.1141194 · Cited by 508
Self-citationFBXW7/hCDC4 Is a General Tumor Suppressor in Human Cancer
Akhoondi, S., Sun, D., von der Lehr, N., Apostolidou, S., Klotz, K., Maljukova, A., Cepeda, D., Fiegl, H., Dofou, D., Marth, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1320 · Cited by 506
Identification of Small Molecule Activators of Cryptochrome
Hirota, T., Lee, J. W., St. John, P. C., Sawa, M., Iwaisako, K., Noguchi, T., Pongsawakul, P. Y., Sonntag, T., Welsh, D. K., Brenner, D. A., et al. (2012) · Science · doi:10.1126/science.1223710 · Cited by 499
Staudt, L. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000109 · Cited by 485
The After-Hours Mutant Reveals a Role for Fbxl3 in Determining Mammalian Circadian Period
Godinho, S. I. H., Maywood, E. S., Shaw, L., Tucci, V., Barnard, A. R., Busino, L., Pagano, M., Kendall, R., Quwailid, M. M., Romero, M. R., et al. (2007) · Science · doi:10.1126/science.1141138 · Cited by 475
Self-citationGregory, M. A., & Hann, S. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469
The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27
Ganoth, D., Bornstein, G., Ko, T. K., Larsen, B., Tyers, M., Pagano, M., & Hershko, A. (2001) · Nature Cell Biology · doi:10.1038/35060126 · Cited by 467
Self-citationRegulation of proteasome activity in health and disease
Schmidt, M., & Finley, D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.012 · Cited by 464
Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics
Yang, Y., Kitagaki, J., Dai, R.-M., Tsai, Y. C., Lorick, K. L., Ludwig, R. L., Pierre, S. A., Jensen, J. P., Davydov, I. V., Oberoi, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0568 · Cited by 441
the ICGC MMML-Seq Project (2012) · Nature Genetics · doi:10.1038/ng.2469 · Cited by 440
Development of Protacs to Target Cancer-promoting Proteins for Ubiquitination and Degradation
Sakamoto, K. M., Kim, K. B., Verma, R., Ransick, A., Stein, B., Crews, C. M., & Deshaies, R. J. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t300009-mcp200 · Cited by 425
The COP9 signalosome: more than a protease
WEI, N., SERINO, G., & DENG, X. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.09.004 · Cited by 409
Chan, C.-H., Morrow, J. K., Li, C.-F., Gao, Y., Jin, G., Moten, A., Stagg, L. J., Ladbury, J. E., Cai, Z., Xu, D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.048 · Cited by 391
Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
Boeckler, F. M., Joerger, A. C., Jaggi, G., Rutherford, T. J., Veprintsev, D. B., & Fersht, A. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805326105 · Cited by 387
Kapuria, V., Peterson, L. F., Fang, D., Bornmann, W. G., Talpaz, M., & Donato, N. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1530 · Cited by 383
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Maser, R. S., Choudhury, B., Campbell, P. J., Feng, B., Wong, K.-K., Protopopov, A., O’Neil, J., Gutierrez, A., Ivanova, E., Perna, I., et al. (2007) · Nature · doi:10.1038/nature05886 · Cited by 377
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
Magnaghi, P., D'Alessio, R., Valsasina, B., Avanzi, N., Rizzi, S., Asa, D., Gasparri, F., Cozzi, L., Cucchi, U., Orrenius, C., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1313 · Cited by 373
Ye, J., Wang, C., Sumpter, R., Brown, M. S., Goldstein, J. L., & Gale, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237238100 · Cited by 366
Skp2-Mediated Degradation of p27 Regulates Progression into Mitosis
Nakayama, K., Nagahama, H., Minamishima, Y. A., Miyake, S., Ishida, N., Hatakeyama, S., Kitagawa, M., Iemura, S.-I., Natsume, T., & Nakayama, K. I. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00131-5 · Cited by 364
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome
Fonzo, A. D., Dekker, M. C. J., Montagna, P., Baruzzi, A., Yonova, E. H., Guedes, L. C., Szczerbinska, A., Zhao, T., Dubbel-Hulsman, L. O. M., Wouters, C. H., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338144.10967.2b · Cited by 364
A UAF1-Containing Multisubunit Protein Complex Regulates the Fanconi Anemia Pathway
Cohn, M. A., Kowal, P., Yang, K., Haas, W., Huang, T. T., Gygi, S. P., & D'Andrea, A. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.031 · Cited by 357
A CDK-Independent Function of Mammalian Cks1
Spruck, C., Strohmaier, H., Watson, M., Smith, A. P. L., Ryan, A., Krek, W., & Reed, S. I. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00210-6 · Cited by 356
The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
King, B., Trimarchi, T., Reavie, L., Xu, L., Mullenders, J., Ntziachristos, P., Aranda-Orgilles, B., Perez-Garcia, A., Shi, J., Vakoc, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.041 · Cited by 347
Building and remodelling Cullin–RING E3 ubiquitin ligases
Lydeard, J. R., Schulman, B. A., & Harper, J. W. (2013) · The EMBO Reports · doi:10.1038/embor.2013.173 · Cited by 327
Milhollen, M. A., Traore, T., Adams-Duffy, J., Thomas, M. P., Berger, A. J., Dang, L., Dick, L. R., Garnsey, J. J., Koenig, E., Langston, S. P., et al. (2010) · Blood · doi:10.1182/blood-2010-03-272567 · Cited by 323
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V. N., Camonis, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0097 · Cited by 321
Tian, Z., D’Arcy, P., Wang, X., Ray, A., Tai, Y.-T., Hu, Y., Carrasco, R. D., Richardson, P., Linder, S., Chauhan, D., et al. (2014) · Blood · doi:10.1182/blood-2013-05-500033 · Cited by 311
Structural Basis of the Cks1-Dependent Recognition of p27Kip1 by the SCFSkp2 Ubiquitin Ligase
Hao, B., Zheng, N., Schulman, B. A., Wu, G., Miller, J. J., Pagano, M., & Pavletich, N. P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.09.003 · Cited by 301
Self-citationWang, C., Gale, M., Keller, B. C., Huang, H., Brown, M. S., Goldstein, J. L., & Ye, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.004 · Cited by 299
FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas
Duan, S., Cermak, L., Pagan, J. K., Rossi, M., Martinengo, C., di Celle, P. F., Chapuy, B., Shipp, M., Chiarle, R., & Pagano, M. (2012) · Nature · doi:10.1038/nature10688 · Cited by 295
Self-citationLin, J. J., Milhollen, M. A., Smith, P. G., Narayanan, U., & Dutta, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2062 · Cited by 292
Bahram, F., von der Lehr, N., Cetinkaya, C., & Larsson, L.-G. (2000) · Blood · doi:10.1182/blood.v95.6.2104 · Cited by 286
Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?
Cohen, P., & Tcherpakov, M. (2010) · Cell · doi:10.1016/j.cell.2010.11.016 · Cited by 271
Chen, Q., Xie, W., Kuhn, D. J., Voorhees, P. M., Lopez-Girona, A., Mendy, D., Corral, L. G., Krenitsky, V. P., Xu, W., Moutouh-de Parseval, L., et al. (2008) · Blood · doi:10.1182/blood-2007-09-112904 · Cited by 264
Schwartz, G. K., LoRusso, P. M., Dickson, M. A., Randolph, S. S., Shaik, M. N., Wilner, K. D., Courtney, R., & O'Dwyer, P. J. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.177 · Cited by 260
Faesen, A. C., Dirac, A. M. G., Shanmugham, A., Ovaa, H., Perrakis, A., & Sixma, T. K. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.034 · Cited by 248
Novel Proteasome Inhibitors to Overcome Bortezomib Resistance
Ruschak, A. M., Slassi, M., Kay, L. E., & Schimmer, A. D. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr160 · Cited by 243
The Multifaceted Roles of USP7: New Therapeutic Opportunities
Nicholson, B., & Suresh Kumar, K. G. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9185-5 · Cited by 240
An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme
Ceccarelli, D. F., Tang, X., Pelletier, B., Orlicky, S., Xie, W., Plantevin, V., Neculai, D., Chou, Y.-C., Ogunjimi, A., Al-Hakim, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.039 · Cited by 235
SCFFBXL3 ubiquitin ligase targets cryptochromes at their cofactor pocket
Xing, W., Busino, L., Hinds, T. R., Marionni, S. T., Saifee, N. H., Bush, M. F., Pagano, M., & Zheng, N. (2013) · Nature · doi:10.1038/nature11964 · Cited by 234
Self-citationThe NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy
Soucy, T. A., Dick, L. R., Smith, P. G., Milhollen, M. A., & Brownell, J. E. (2010) · Genes & Cancer · doi:10.1177/1947601910382898 · Cited by 225
Specific Small Molecule Inhibitors of Skp2-Mediated p27 Degradation
Wu, L., Grigoryan, A. V., Li, Y., Hao, B., Pagano, M., & Cardozo, T. J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.09.015 · Cited by 219
Self-citationThe 26 S Proteasome: From Basic Mechanisms to Drug Targeting
Navon, A., & Ciechanover, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.018481 · Cited by 214
Chen, J., Dexheimer, T. S., Ai, Y., Liang, Q., Villamil, M. A., Inglese, J., Maloney, D. J., Jadhav, A., Simeonov, A., & Zhuang, Z. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.08.014 · Cited by 214
Diverse functions with a common regulator: Ubiquitin takes command of an AAA ATPase
Ye, Y. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.01.005 · Cited by 213
Skp2-dependent degradation of p27kip1 is essential for cell cycle progression
Kossatz, U., Dietrich, N., Zender, L., Buer, J., Manns, M. P., & Malek, N. P. (2004) · Genes & Development · doi:10.1101/gad.321004 · Cited by 194
Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer
Li, L., Wang, M., Yu, G., Chen, P., Li, H., Wei, D., Zhu, J., Xie, L., Jia, H., Shi, J., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju083 · Cited by 188
Selective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47.
Weinstock, J., Wu, J., Cao, P., Kingsbury, W. D., McDermott, J. L., Kodrasov, M. P., McKelvey, D. M., Suresh Kumar, K. G., Goldenberg, S. J., Mattern, M. R., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200276j · Cited by 187
Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma
Kubiczkova, L., Pour, L., Sedlarikova, L., Hajek, R., & Sevcikova, S. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12279 · Cited by 187
Matsuoka, S., Oike, Y., Onoyama, I., Iwama, A., Arai, F., Takubo, K., Mashimo, Y., Oguro, H., Nitta, E., Ito, K., et al. (2008) · Genes & Development · doi:10.1101/gad.1621808 · Cited by 185
βTrCP- and Rsk1/2-Mediated Degradation of BimEL Inhibits Apoptosis
Dehan, E., Bassermann, F., Guardavaccaro, D., Vasiliver-Shamis, G., Cohen, M., Lowes, K. N., Dustin, M., Huang, D. C. S., Taunton, J., & Pagano, M. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.020 · Cited by 185
Self-citationTeratogenic effects of thalidomide: molecular mechanisms
Ito, T., Ando, H., & Handa, H. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0619-9 · Cited by 182
NEDD8 Pathways in Cancer, Sine Quibus Non
Watson, I. R., Irwin, M. S., & Ohh, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.002 · Cited by 181
Gai, X., Ghezzi, D., Johnson, M. A., Biagosch, C. A., Shamseldin, H. E., Haack, T. B., Reyes, A., Tsukikawa, M., Sheldon, C. A., Srinivasan, S., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.07.016 · Cited by 179
Ablation of Fbxw7 Eliminates Leukemia-Initiating Cells by Preventing Quiescence
Takeishi, S., Matsumoto, A., Onoyama, I., Naka, K., Hirao, A., & Nakayama, K. I. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.026 · Cited by 178
Price, C. T., Al-Khodor, S., Al-Quadan, T., Santic, M., Habyarimana, F., Kalia, A., & Kwaik, Y. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000704 · Cited by 177
Bonnen, P. E., Yarham, J. W., Besse, A., Wu, P., Faqeih, E. A., Al-Asmari, A. M., Saleh, M. A. M., Eyaid, W., Hadeel, A., He, L., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.07.017 · Cited by 177
Onoyama, I., Tsunematsu, R., Matsumoto, A., Kimura, T., de Alborán, I. M., Nakayama, K., & Nakayama, K. I. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062299 · Cited by 177
Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7
Thompson, B. J., Jankovic, V., Gao, J., Buonamici, S., Vest, A., Lee, J. M., Zavadil, J., Nimer, S. D., & Aifantis, I. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080277 · Cited by 173
Skaar, J. R., D'Angiolella, V., Pagan, J. K., & Pagano, M. (2009) · Cell · doi:10.1016/j.cell.2009.05.040 · Cited by 168
Self-citationFbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
Busino, L., Millman, S. E., Scotto, L., Kyratsous, C. A., Basrur, V., O’Connor, O., Hoffmann, A., Elenitoba-Johnson, K. S., & Pagano, M. (2012) · Nature Cell Biology · doi:10.1038/ncb2463 · Cited by 167
Self-citationWei, D., Li, H., Yu, J., Sebolt, J. T., Zhao, L., Lawrence, T. S., Smith, P. G., Morgan, M. A., & Sun, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2866 · Cited by 164
Linear ubiquitination: a newly discovered regulator of cell signalling
Rieser, E., Cordier, S. M., & Walczak, H. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.11.007 · Cited by 159
An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase
Orlicky, S., Tang, X., Neduva, V., Elowe, N. H., Brown, E., Sicheri, F., & Tyers, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1646 · Cited by 153
Activating the ubiquitin family: UBA6 challenges the field
Groettrup, M., Pelzer, C., Schmidtke, G., & Hofmann, K. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.01.005 · Cited by 151
Chou, T., Li, K., Frankowski, K. J., Schoenen, F. J., & Deshaies, R. J. (2013) · ChemMedChem · doi:10.1002/cmdc.201200520 · Cited by 149
Chen, B. B., Coon, T. A., Glasser, J. R., McVerry, B. J., Zhao, J., Zhao, Y., Zou, C., Ellis, B. M., Sciurba, F. C., Zhang, Y., et al. (2013) · Nature Immunology · doi:10.1038/ni.2565 · Cited by 147
Aghajan, M., Jonai, N., Flick, K. M., Fu, F., Luo, M., Cai, X., Ouni, I., Pierce, N. W., Tang, X., Lomenick, B., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1645 · Cited by 144
Buckley, D. L., & Crews, C. (2014) · Angewandte Chemie · doi:10.1002/anie.201307761 · Cited by 142
MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL
Baraniskin, A., Birkenkamp-Demtroder, K., Maghnouj, A., Zöllner, H., Munding, J., Klein-Scory, S., Reinacher-Schick, A., Schwarte-Waldhoff, I., Schmiegel, W., & Hahn, S. A. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs020 · Cited by 142
PI3Kδ Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic
Fruman, D. A., & Rommel, C. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0249 · Cited by 141
Regulation of c-Myc Ubiquitination Controls Chronic Myelogenous Leukemia Initiation and Progression
Reavie, L. B., Buckley, S. M., Loizou, E., Takeishi, S., Aranda-Orgillés, B., Ndiaye‐Lobry, D., Abdel-Wahab, O. I., Ibrahim, S., Nakayama, K. I., & Aifantis, I. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.025 · Cited by 133
Kuchay, S., Duan, S., Schenkein, E., Peschiaroli, A., Saraf, A., Florens, L. A., Washburn, M. P., & Pagano, M. (2013) · Nature Cell Biology · doi:10.1038/ncb2731 · Cited by 132
Self-citationFlavopiridol, An Inhibitor of Transcription: Implications, Problems and Solutions
Blagosklonny, M. V. (2004) · Cell Cycle · doi:10.4161/cc.3.12.1278 · Cited by 121
The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation
Moran-Crusio, K., King, B., Reavie, L. B., & Aifantis, I. (2010) · Oncogene · doi:10.1038/onc.2010.222 · Cited by 117
Mackintosh, C., Ordóñez, J. L., García-Domínguez, D. J., Sevillano, V., Llombart‐Bosch, A., Szuhai, K., Scotlandi, K., Alberghini, M., Sciot, R., Sinnaeve, F., et al. (2011) · Oncogene · doi:10.1038/onc.2011.317 · Cited by 116
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer
Rocca, A., Farolfi, A., Bravaccini, S., Schirone, A., & Amadori, D. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.870555 · Cited by 113
Basse, N., Kaar, J. L., Settanni, G., Joerger, A. C., Rutherford, T. J., & Fersht, A. R. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.12.011 · Cited by 113
Milhollen, M. A., Thomas, M. P., Narayanan, U., Traore, T., Riceberg, J., Amidon, B., Bence, N., Bolen, J. B., Brownell, J. E., Dick, L. R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.009 · Cited by 109
Chen, B. B., Glasser, J. R., Coon, T. A., Zou, C., Miller, H. L., Fenton, M. J., McDyer, J. F., Boyiadzis, M. M., & Mallampalli, R. K. (2012) · Blood · doi:10.1182/blood-2011-06-358911 · Cited by 107
Blank, J. L., Liu, X. J., Cosmopoulos, K., Bouck, D. C., Garcia, K., Bernard, H., Tayber, O., Hather, G., Liu, R., Narayanan, U., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1729 · Cited by 104
Ueki, T., Nishidate, T., Park, J. H., Lin, M., Shimo, A., Hirata, K., Nakamura, Y., & Katagiri, T. (2008) · Oncogene · doi:10.1038/onc.2008.186 · Cited by 95
E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin
Huang, H., Ceccarelli, D. F. J., Orlicky, S. M., St‐Cyr, D. J., Ziemba, A. J., Garg, P., Plamondon, S., Auer, M., Sidhu, S. S., Marinier, A., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1412 · Cited by 94
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis
Li, H., Tan, M., Jia, L., Wei, D., Zhao, Y., Chen, G., Xu, J., Zhao, L., Thomas, D. G., Beer, D. G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70297 · Cited by 93
Chen, J. J., Tsu, C. A., Gavin, J. M., Milhollen, M. A., Bruzzese, F. J., Mallender, W. D., Sintchak, M. D., Bump, N. J., Yang, X., Ma, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279984 · Cited by 91
Bioluminescent imaging of Cdk2 inhibition in vivo
Zhang, G.-J., Safran, M., Wei, W., Sorensen, E. J., Lassota, P., Zhelev, N., Neuberg, D. S., Shapiro, G. I., & Kaelin, W. G. (2004) · Nature Medicine · doi:10.1038/nm1047 · Cited by 90
Nangle, S. N., Xing, W., & Zheng, N. (2013) · Cell Research · doi:10.1038/cr.2013.136 · Cited by 88
Targeting nuclear kinases in cancer: Development of cell cycle kinase inhibitors
Pitts, T. M., Davis, S. L., Eckhardt, S. G., & Bradshaw‐Pierce, E. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.010 · Cited by 88
Pan, W., Zhou, J.-J., Yu, C. Y., Xu, Y., Guo, L.-J., Zhang, H., Zhou, D., Song, F., & Fan, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.495069 · Cited by 85
A Gatekeeper Residue for NEDD8-Activating Enzyme Inhibition by MLN4924
Toth, J. I., Yang, L., Dahl, R. S., & Petroski, M. D. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.02.006 · Cited by 84
Abbas, T., Mueller, A. C., Shibata, E., Keaton, M., Rossi, M., & Dutta, A. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.003 · Cited by 84
Pan, H., Chou, H.-Y. E., Liu, S.-H., Peng, S., Liu, C.-L., & Hsu, H. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3500 · Cited by 84
Regulation of the CRL4Cdt2 Ubiquitin Ligase and Cell-Cycle Exit by the SCFFbxo11 Ubiquitin Ligase
Rossi, M., Duan, S., Jeong, Y., Horn, M., Saraf, A., Florens, L. A., Washburn, M. P., Antebi, A., & Pagano, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.004 · Cited by 83
Self-citationGu, Y., Kaufman, J. L., Bernal, L., Torre, C., Matulis, S. M., Harvey, R. D., Chen, J., Sun, S., Boise, L., & Lonial, S. (2014) · Blood · doi:10.1182/blood-2013-08-521914 · Cited by 83
Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells
Suzuki, É., Demo, S. D., Deu, E., Keats, J. J., Arastu‐Kapur, S., Bergsagel, P. L., Bennett, M. K., & Kirk, C. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027996 · Cited by 78
Rico-Bautista, E., Yang, C.-C., Lu, L., Roth, G. P., & Wolf, D. A. (2010) · BMC Biology · doi:10.1186/1741-7007-8-153 · Cited by 75
Chen, B. B., Glasser, J. R., Coon, T. A., & Mallampalli, R. K. (2011) · Oncogene · doi:10.1038/onc.2011.432 · Cited by 74
P97/CDC-48: Proteostasis control in tumor cell biology
Fessart, D., Marza, E., Taouji, S., Delom, F., & Chevet, É. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.030 · Cited by 74
NEDD8 links cullin-RING ubiquitin ligase function to the p97 pathway
den Besten, W., Verma, R., Kleiger, G., Oania, R. S., & Deshaies, R. J. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2269 · Cited by 71
Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells
Takeishi, S., & Nakayama, K. I. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.259 · Cited by 71
Targeting F Box Protein Fbxo3 To Control Cytokine-Driven Inflammation
Mallampalli, R. K., Coon, T. A., Glasser, J. R., Wang, C., Dunn, S. R., Weathington, N. M., Zhao, J., Zou, C., Zhao, Y., & Chen, B. B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300456 · Cited by 70
Mattern, M. R., Wu, J., & Nicholson, B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.005 · Cited by 67
Mackintosh, C., García-Domínguez, D. J., Ordóñez, J. L., Ginel-Picardo, A., Smith, P. G., Sacristán, M. P., & de Álava, E. (2012) · Oncogene · doi:10.1038/onc.2012.153 · Cited by 65
A novel small-molecule inhibitor of NF-κB signaling
Nakajima, H., Fujiwara, H., Furuichi, Y., Tanaka, K., & Shimbara, N. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.166 · Cited by 64
Blees, J. S., Bokesch, H. R., Rübsamen, D., Schulz, K. L., Milke, L., Bajer, M. M., Gustafson, K. R., Henrich, C. J., McMahon, J. B., Colburn, N. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046567 · Cited by 63
Pavlides, S. C., Huang, K., Reid, D. A., Wu, L. I., Blank, S. V., Mittal, K., Guo, L., Rothenberg, E., Rueda, B. R., Cardozo, T. J., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1757 · Cited by 61
Skp-cullin-F box E3 ligase component FBXL2 ubiquitinates Aurora B to inhibit tumorigenesis
Chen, B. B., Glasser, J. R., Coon, T. A., & Mallampalli, R. K. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.271 · Cited by 60
Li, J., Ng, E. K. O., Ng, Y. P., Wong, C. Y., Yu, J. Q., Jin, H., Cheng, V. Y. Y., Go, M. Y. Y., Cheung, P. K. F., Ebert, M. P. A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605202 · Cited by 56
Villamil, M. A., Chen, J., Liang, Q., & Zhuang, Z. (2012) · Biochemistry · doi:10.1021/bi3000512 · Cited by 54
Interplay between poxviruses and the cellular ubiquitin/ubiquitin‐like pathways
Zhang, L., Villa, N., & McFadden, G. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.023 · Cited by 50
Villamil, M. A., Liang, Q., Chen, J., Choi, Y. S., Hou, S., Lee, K. H., & Zhuang, Z. (2012) · Biochemistry · doi:10.1021/bi300845s · Cited by 49
GS-1101: A Delta-Specific PI3K Inhibitor in Chronic Lymphocytic Leukemia
Macias‐Perez, I., & Flinn, I. W. (2012) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0142-1 · Cited by 47
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer
Maerken, T. V., Rihani, A., Goethem, A. V., Paepe, A. D., Speleman, F., & Vandesompele, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.002 · Cited by 47
Smith, M. A., Maris, J. M., Gorlick, R. G., Kolb, E. A., Lock, R. B., Carol, H., Keir, S. T., Reynolds, C. P., Kang, M. H., Morton, C. L., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23357 · Cited by 41
Inhibition of homologue of Slimb (HOS) function sensitizes human melanoma cells for apoptosis.
Солдатенков, В. А., Dritschilo, A., Ronai, Z. A., & Fuchs, S. Y. (1999) · PubMed · Cited by 39
Signal-Induced Disassembly of the SCF Ubiquitin Ligase Complex by Cdc48/p97
Yen, J. L., Flick, K. M., Papagiannis, C. V., Mathur, R., Tyrrell, A., Ouni, I., Kaake, R. M., Huang, L., & Kaiser, P. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.015 · Cited by 38
Xu, W., Toth, J. I., da Silva, S. D., Paiva, S.-L., Lukkarila, J. L., Hurren, R., MacLean, N., Sukhai, M., Bhattacharjee, R., Goard, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0093530 · Cited by 38
Mir, A., Sritharan, K., Mittal, K., Vasli, N., Araujo-Sousa, C., Jamil, T., Rafiq, M., Anwar, Z., Mikhailov, A., Rauf, S., et al. (2014) · Human Genetics · doi:10.1007/s00439-014-1438-0 · Cited by 35
HIV-1 Vpu Interference with Innate Cell-mediated Immune Mechanisms
Sandberg, J. K., Andersson, S. K., Bächle, S. M., Nixon, D. F., & Moll, M. (2012) · Current HIV Research · doi:10.2174/157016212800792513 · Cited by 29
Lee, B., Finley, D. J., & King, R. W. (2012) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch120078 · Cited by 24
Seeley, A. H., Durham, M. A., Micale, M. A., Wesolowski, J., Foerster, B. R., & Martin, D. M. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36569 · Cited by 16
High‐Throughput Screening for Inhibitors of the Cks1–Skp2 Interaction
Huang, K., & Vassilev, L. T. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)99047-2 · Cited by 15
Nature Biotechnology's academic spinouts of 2013
Bouchie, A. J., Allison, M., Webb, S., & DeFrancesco, L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2846 · Cited by 14
Wiley, D. J., Juan, I., Le, H., Cai, X., Baumbach, L. L., Beattie, C. E., & D’Urso, G. (2014) · F1000Research · doi:10.12688/f1000research.4188.1 · Cited by 5
Cited by
Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891
The role of ubiquitination in tumorigenesis and targeted drug discovery
Deng, L., Meng, T., Chen, L., Wei, W., & Wang, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0107-0 · Cited by 744
Ubiquitin ligases in oncogenic transformation and cancer therapy
Senft, D., Qi, J., & Ronai, Z. A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.105 · Cited by 489
A review on the pharmacological effects of vitexin and isovitexin
He, M., Min, J.-W., Kong, W.-L., He, X.-H., Li, J.-X., & Peng, B.-W. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.09.011 · Cited by 472
E3 ubiquitin ligases: styles, structures and functions
Yang, Q., Zhao, J., Chen, D., & Wang, Y. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00043-2 · Cited by 435
Metadata
- Authors
- Skaar, J. R., Pagan, J. K., & Pagano, M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-11-14
- Volume
- 13
- Issue
- 12
- Pages
- 889-903
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2055092042
- Cited by
- 335
- References
- 172
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.